HomeOTLC • OTCMKTS
add
Oncotelic Therapeutics Inc
Previous close
$0.055
Day range
$0.051 - $0.059
Year range
$0.017 - $0.070
Market cap
19.53M USD
Avg Volume
59.60K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 101.10K | -39.54% |
Net income | -298.72K | 26.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.17K | -58.11% |
Total assets | 26.67M | -11.03% |
Total liabilities | 19.48M | 4.06% |
Total equity | 7.18M | — |
Shares outstanding | 408.29M | — |
Price to book | 2.76 | — |
Return on assets | -0.95% | — |
Return on capital | -1.23% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -298.72K | 26.91% |
Cash from operations | -166.96K | 27.86% |
Cash from investing | — | — |
Cash from financing | 160.00K | -36.00% |
Net change in cash | -6.96K | -137.42% |
Free cash flow | -63.37K | 58.48% |
About
Founded
1988
Headquarters
Website
Employees
26
